Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Enhanced Co-Expression Extrapolation (COXEN) Gene Selection Method for Building Anti-Cancer Drug Response Prediction Models
  2. Zhu, Yitan; Brettin, Thomas; Evrard,Yvonne; Xia, Fangfang; Partin, Alexander; Shukla, Maulik; Yoo, Hyunseung; Doroshow, James H; Stevens, Rick L
  3. Genes. 2020, Sep 11; 11(9): pii: E1070.
  1. 2.   Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer
  2. Basudhar, Debashree; Glynn, Sharon A; Greer, Madison; Somasundaram, Veena; No, Jae Hong; Scheiblin, David; Garrido, Pablo; Heinz, Will; Ryan, Aideen E; Weiss, Jonathan M; Cheng, Robert Y S; Ridnour, Lisa; Lockett, Stephen; McVicar, Daniel; Ambs, Stefan; Wink, David
  3. Proceedings of the National Academy of Sciences of the United States of America. 2017, Dec 05; 114(49): 13030-13035.
  1. 3.   Intentional genetic introgression influences survival of adults and subadults in a small, inbred felid population
  2. Benson, J. F.; Hostetler, J. A.; Onorato, D. P.; Johnson, W. E.; Roelke, M. E.; O'Brien, S. J.; Jansen, D.; Oli, M. K.
  3. Journal of Animal Ecology. 2011, Sep; 80(5): 958-967.
  1. 4.   Polymorphisms in oxidative stress and inflammation pathway genes, low-dose ionizing radiation, and the risk of breast cancer among US radiologic technologists
  2. Schonfeld, S. J.; Bhatti, P.; Brown, E. E.; Linet, M. S.; Simon, S. L.; Weinstock, R. M.; Hutchinson, A. A.; Stovall, M.; Preston, D. L.; Alexander, B. H.; Doody, M. M.; Sigurdson, A. J.
  3. Cancer Causes & Control. 2010, Nov; 21(11): 1857-1866.
  1. 5.   Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cells
  2. Nath, N.; Chattopadhyay, M.; Kodela, R.; Tian, S.; Vlismas, P.; Boring, D.; Crowell, J. A.; Kashfi, K.
  3. Biochemical Pharmacology. 2010, Jun; 79(12): 1759-1771.
  1. 6.   Cancer and Inflammation: Promise for Biologic Therapy
  2. Demaria, S.; Pikarsky, E.; Karin, M.; Coussens, L. M.; Chen, Y. C.; El-Omar, E. M.; Trinchieri, G.; Dubinett, S. M.; Mao, J. T.; Szabo, E.; Krieg, A.; Weiner, G. J.; Fox, B. A.; Coukos, G.; Wang, E.; Abraham, R. T.; Carbone, M.; Lotze, M. T.
  3. Journal of Immunotherapy. 2010, May; 33(4): 335-351.
  1. 7.   Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells
  2. Moody, T. W.; Switzer, C.; Santana-Flores, W.; Ridnour, L. A.; Berna, M.; Thill, M.; Jensen, R. T.; Sparatore, A.; Del Soldato, P.; Yeh, G. C.; Roberts, D. D.; Giaccone, G.; Wink, D. A.
  3. Lung Cancer. 2010, May; 68(2): 154-160.
  1. 8.   PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)
  2. Dossus, L.; Kaaks, R.; Canzian, F.; Albanes, D.; Berndt, S. I.; Boeing, H.; Buring, J.; Chanock, S. J.; Clavel-Chapelon, F.; Feigelson, H. S.; Gaziano, J. M.; Giovannucci, E.; Gonzalez, C.; Haiman, C. A.; Hallmans, G.; Hankinson, S. E.; Hayes, R. B.; Henderson, B. E.; Hoover, R. N.; Hunter, D. J.; Khaw, K. T.; Kolonel, L. N.; Kraft, P.; Ma, J.; Le Marchand, L.; Lund, E.; Peeters, P. H. M.; Stampfer, M.; Stram, D. O.; Thomas, G.; Thun, M. J.; Tjonnel, A.; Trichopoulos, D.; Tumino, R.; Riboli, E.; Virtamo, J.; Weinstein, S. J.; Yeager, M.; Ziegler, R. G.; Cox, D. G.
  3. Carcinogenesis. 2010, Mar; 31(3): 455-461.
  1. 9.   Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence-Data from a Randomized Clinical Trial
  2. Barry, E. L.; Sansbury, L. B.; Grau, M. V.; Ali, I. U.; Tsang, S.; Munroe, D. J.; Ahnen, D. J.; Sandler, R. S.; Saibil, F.; Gui, J.; Bresalier, R. S.; McKeown-Eyssen, G. E.; Burke, C.; Baron, J. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(10): 2726-2733.
  1. 10.   Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies
  2. Danforth, K. N.; Hayes, R. B.; Rodriguez, C.; Yu, K.; Sakoda, L. C.; Huang, W. Y.; Chen, B. E.; Chen, J. B.; Andriole, G. L.; Calle, E. E.; Jacobs, E. J.; Chu, L. W.; Figueroa, J. D.; Yeager, M.; Platz, E. A.; Michaud, D. S.; Chanock, S. J.; Thun, M.
  3. Carcinogenesis. 2008 29(3): 568-572.
  1. 11.   Altered Gene Expression Profiles Define Pathways in Colorectal Cancer Cell Lines Affected by Celecoxib
  2. Fatima, N.; Yi, M.; Ajaz, S.; Stephens, R. M.; Stauffer, S.; Greenwald, P.; Munroe, D. J.; Ali, I. U.
  3. Cancer Epidemiology Biomarkers & Prevention. 2008 17(11): 3051-3061.
  1. 12.   Proline oxidase, a p53-induced gene, targets COX-2/PGE(2) signaling to induce apoptosis and inhibit tumor growth in colorectal cancers
  2. Liu, Y.; Borchert, G. L.; Surazynski, A.; Phang, J. M.
  3. Oncogene. 2008 27(53): 6729-6737.
  1. 13.   The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems
  2. Goldsmith, M. E.; Aguila, A.; Steadman, K.; Martinez, A.; Steinberg, S. M.; Alley, M. C.; Waud, W. R.; Bates, S. E.; Fojo, T.
  3. Molecular Cancer Therapeutics. 2007, Feb; 6(2): 496-505.
  1. 14.   Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells
  2. Lou, J. R.; Fatima, N.; Xiao, Z.; Stauffer, S.; Smythers, G.; Greenwald, P.; Ali, I. U.
  3. Cancer Epidemiology Biomarkers & Prevention. 2006, Sep; 15(9): 1598-1606.
  1. 15.   Micro-MRI methods to detect renal cysts in mice
  2. Kobayashi, H.; Kawamoto, S.; Brechbiel, M. W.; Jo, S. K.; Hu, X. Z.; Yang, T. X.; Diwan, B. A.; Waldmann, T. A.; Schnermann, J.; Choyke, P. L.; Star, R. A.
  3. Kidney International. 2004 65(4): 1511-1516.
  1. 16.   Fraction of cases of acquired immunodeficiency syndrome prevented by the interactions of identified restriction gene variants
  2. Silverberg, M. J.; Smith, M. W.; Chmiel, J. S.; Detels, R.; Margolick, J. B.; Rinaldo, C. R.; O'Brien, S. J.; Munoz, A.
  3. American Journal of Epidemiology. 2004 159(3): 232-241.
  1. 17.   Serum proteomic profiles suggest celecoxib-modulated targets and response predictors
  2. Zhen, X. A.; Luke, B. T.; Izmirlian, G.; Umar, A.; Lynch, P. M.; Phillips, R. K. S.; Patterson, S.; Conrads, T. P.; Veenstra, T. D.; Greenwald, P.; Hawk, E. T.; Ali, L. U.
  3. Cancer Research. 2004 64(8): 2904-2909.
  1. 18.   Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents
  2. Zhu, J. X.; Song, X. Q.; Lin, H. P.; Young, D. C.; Yan, S. Q.; Marquez, V. E.; Chen, C. S.
  3. Journal of the National Cancer Institute. 2002 94(23): 1745-1757.
  1. 19.   Cytochrome c oxidase assembly in primates is sensitive to small evolutionary variations in amino acid sequence
  2. Barrientos, A.; Muller, S.; Dey, R.; Wienberg, J.; Moraes, C. T.
  3. Molecular Biology and Evolution. 2000 17(10): 1508-1519.
  1. 20.   Mutations in a conserved enteroviral RNA oligonucleotide sequence affect positive strand viral RNA synthesis
  2. Willian, S.; Tracy, S.; Chapman, N.; Leser, S.; Romero, J.; Shapiro, B.; Currey, K.
  3. Archives of Virology. 2000 145(10): 2061-2086.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel